Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 24 of 24 publications.

Bhashyam SS, Shane LG, Lewis HB, de la Cruz M, Galinsky J, Demchuk K, Waite NM, Lazarus JV, Salisbury DM. Results from the COVID-19 vaccines discrete choice experiment pre-test qualitative interviews in Canada, Germany, the UK, and US general population. Poster presented at the ID Week 2023; October 3, 2023. Washington, DC. [abstract] Open Forum Infect Dis. 2023 Nov 27; 10(Suppl 2):S263-4. doi: 10.1093/ofid/ofad500.1208

Njue A, Nuabor W, Lyall M, Margulis A, Mauskopf J, Curcio D, Kurosky S, Gessner BD, Begier E. Systematic literature review of risk factors for poor outcomes among adults with respiratory syncytial virus infection in high-income countries. Open Forum Infect Dis. 2023 Oct 20;10(11):ofad513. doi: 10.1093/ofid/ofad513

Hunt NB, Pajouheshnia R, Salih A, van Doorn S, Souverein PC, Bazelier MT, Klungel OH, Gardarsdottir H. Prescribing of low-dose rivaroxaban in patients with atherosclerotic cardiovascular disease in the United Kingdom and the Netherlands. Br J Clin Pharmacol. 2023 Jul;89(7):2263-71. doi: 10.1111/bcp.15708

van den Dries CJ, Pajouheshnia R, van den Ham HA, Souverein P, Moons KGM, Hoes AW, Geersing GJ, van Doorn S. Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Br J Clin Pharmacol. 2023 Feb;89(2):751-61. doi: 10.1111/bcp.15534

Romano C, Mayorga M, Ruiz-Guinazu J, Trudel GC, Fehnel S, McQuarrie K, Chan EKH, Katz EG. Evaluation of measures for the assessment of Covid-19 signs and symptoms in children and adolescents. Poster presented at the IDWeek 2022 Conference; October 21, 2022. Washington, DC. [abstract] Open Forum Infect Dis. 2022 Dec 15; 9(Issue Supplement_2):1061. doi: 10.1093/ofid/ofac492.902

Trennery CL, Martin S, Kosa K, Demetriou L, Joshi AV. Patient perceptions of treatment success in uncomplicated urinary tract infection. Poster presented at the IDWeek 2022; October 22, 2022. Washington, DC. [abstract] Open Forum Infect Dis. 2022 Dec; 9(Suppl 2):S917-8. doi: 10.1093/ofid/ofac492.1861

Patel B, Murphy RE, Karanth S, Shiffaraw S, Peters, Jr RM, Hohmann SF, Greenberg RS. Surge in incidence and coronavirus disease 2019 hospital risk of death, United States, September 2020 to March 2021. Open Forum Infect Dis. 2022 Oct;9(10). doi: 10.1093/ofid/ofac424

Gemmeke M, Koster ES, Pajouheshnia R, Kruijtbosch M, Taxis k, Bouvy ML. Using pharmacy dispensing data to predict falls in older individuals. Br J Clin Pharmacol. 2021 Mar;87(3):1282-90. doi: 10.1111/bcp.14506

Mansfield CA, Metcalfe KA, Snyder C, Lindeman GJ, Posner J, Friedman S, Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Lynch HT, Narod SA, Evans DG, Liede A. Preferences for breast cancer prevention among women with a BRCA1 or BRCA2 mutation. Hered Cancer Clin Pract. 2020 Sep 29;18(20). doi: 10.1186/s13053-020-00152-z

Carreno JJ, Tam IM, Meyers JL, Esterberg E, Candrilli SD, Lodise TP. Corrigendum to: Longitudinal, nationwide, cohort study to assess incidence, outcomes, and costs associated with complicated urinary tract infection. Open Forum Infect Dis. 2020 Jan 13;7(1):ofz536. doi: 10.1093/ofid/ofz536

Carreno JJ, Tam IM, Meyers JL, Esterberg E, Candrilli SD, Lodise TP. Longitudinal, nationwide, cohort study to assess incidence, outcomes, and costs associated with complicated urinary tract infection. Open Forum Infect Dis. 2019 Nov;6(11):ofz446. doi: 10.1093/ofid/ofz446

Rhee C, Wang R, Jentzsch MS, Hsu H, Kawai AT, Jin R, Horan K, Broadwell C, Lee GM. Impact of the 2012 Medicaid health care-acquired conditions policy on catheter-associated urinary tract infection and vascular catheter-associated infection billing rates. Open Forum Infect Dis. 2018 Sep 4;5(9). doi: 10.1093/ofid/ofy204

Nance R, Vannappagari V, Johannes C, Calingaert B, Saltus C, Boswell S, Rodriguez B, Moore R, Eron J, Geng E, Mathews WC, Saag MS, Kitahata M, Delaney JAC, Crane HM, Centers For AIDS Research Network of Integrated Clinical Systems (CNICS). Viral failure among persons living with HIV initiating dolutegravir-based vs. other recommended regimens in real-world clinical care settings. Poster presented at the IDWeek 2017 Conference; October 2017. San Diego, CA. [abstract] Open Forum Infect Dis. 2017 Oct 4; 4((Suppl 1)):S39. doi: 10.1093/ofid/ofx162.095

Baker M, Jankosky C, Yih K, Gruber S, Li L, Cocoros N, Lipowicz H, Coronel-Moreno C, Feibelmann S, Lin N, McMahill-Walraven C, Menschik D, Selvan M, Selvam N, Tilney RC, Zichittella L, Lee G, Kawai AT. The risk of febrile seizures following influenza and 13-valent pneumococcal conjugate vaccines. Poster presented at the 2017 Infectious Disease Week Conference; October 6, 2017. San Diego, CA. [abstract] Open Forum Infect Dis. 2017 Oct; 4(Suppl 1):S464-5. doi: 10.1093/ofid/ofx163.1187

Ghantoji SS, Karanth S, El Haddad L, Park AK, Lairson DR, Chemaly RF. Clinical and economic burden of respiratory viral infections in hematopoietic stem cell transplant recipients: the MD Anderson experience. Poster presented at the IDWeek 2017 Conference; October 2017. San Diego, CA. [abstract] Open Forum Infect Dis. 2017 Oct; 4(Supple 1):319. doi: 10.1093/ofid/ofx163.748

Becker-Dreps S, Butler AM, McGrath LJ, Boggess KA, Weber DJ, Dongmei L, Hudgens MG, Layton JB. Effectiveness of prenatal Tdap immunization in the prevention of infant pertussis in the United States. Presented at the IDWeek 2017 Conference; October 1, 2017. San Diego, CA. [abstract] Open Forum Infect Dis. 2017 Oct; 4(Suppl 1):S68. doi: 10.1093/ofid/ofx162.163

Weatherall M, Aantaa R, Conti G, Garratt CJ, Pohjanjousi P, Lewis MA, Moore N, Perez-Gutthann S. A multinational, drug utilisation study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU. Br J Clin Pharmacol. 2017 Sep;83(9):2066-76. doi: 10.1111/bcp.13293

Mansfield C, Thomas N, Gebben D, Lucas M, Hauber AB. Preferences for multiple sclerosis treatments: using a discrete-choice experiment to examine differences across subgroups of US patients. Int J MS Care. 2017 Jul;19(4):172-83. doi: 10.7224/1537-2073.2016-039

Warren DK, Nickel KB, Wallace AE, Mines D, Tian F, Symons WJ, Fraser VJ, Olsen MA. Risk factors for surgical site infection after cholecystectomy. Open Forum Infect Dis. 2017 Feb 22;4(2):ofx036. doi: 10.1093/ofid/ofx036

Schmiedl S, Fischer R, Ibanez L, Fortuny J, Thurmann P, Ballarin E, Ferrer P, Sabate M, Rottenkolber D, Gerlach R, Tauscher M, Reynolds R, Hasford J, Rottenkolber M. Tiotropium Respimat® vs. HandiHaler®: real-life usage and TIOSPIR trial generalizability. Br J Clin Pharmacol. 2016 Feb;81(2):379-88. doi: 10.1111/bcp.12808

Hall AJ, Naleway AL, Esterberg EJ, Moua K, Donald J, DeBess EE, Biggs C, Schmidt M. Incidence of medically-attended acute gastroenteritis and norovirus infection across the age spectrum. Poster presented at the IDWeek 2015 Conference; October 2015. San Diego, CA. [abstract] Open Forum Infect Dis. 2015 Dec; 2(1 Suppl). doi: 10.1093/ofid/ofv131.181

Kawai AT, Jin R, Soumerai S, Vaz LE, Rett M, Lee G. Impact of nonpayment for preventable infections on billing rates for central line associated bloodstream infections and catheter-associated urinary tract infections. Presented at the 2014 Infectious Disease Week Conference; October 10, 2014. Philadelphia, PA. [abstract] Open Forum Infect Dis. 2014 Dec; 1(Suppl_1):S44. doi: 10.1093/ofid/ofu051.118

Garcia Rodriguez LA, Duque A, Castellsague J, Perez-Gutthann S, Stricker BH. A cohort study on the risk of acute liver injury among users of ketoconazole and other antifungal drugs. Br J Clin Pharmacol. 1999 Dec 1;48(6):847-52.

Garcia Rodriguez LA, Perez GS. Use of the UK general practice research database for pharmacoepidemiology. Br J Clin Pharmacol. 1998 May 1;45(5):419-25.